Dr. Ashley Nelson -- Pharmaceutical Payment Report
This page provides a comprehensive transparency report for Dr. Ashley Nelson, a Rheumatology physician based in City, IN. All payment data is sourced from the CMS Open Payments (Sunshine Act) database. Dr. Ashley Nelson has received $112,809.76 in total pharmaceutical industry payments across 1 transactions from 1 pharmaceutical companies.
Physician Profile
The following profile information is sourced from the National Provider Identifier (NPI) registry and CMS Open Payments records.
- Full Name: Dr. Ashley Nelson
- Medical Specialty: Rheumatology
- Practice Location: City, IN, Indiana
- NPI Number: 1425881981
- Transparency Score: 50/100
- Payment Records Span: 2025-11-02 to 2025-11-02
Payment Summary
Dr. Ashley Nelson has received a total of $112,809.76 in pharmaceutical industry payments across 1 recorded transactions in the CMS Open Payments database. The average payment amount is $112,809.76 per transaction.
- Total Payments Received: $112,809.76
- Number of Transactions: 1
- Average Payment: $112,809.76
- Transparency Score: 50/100 -- This score reflects the overall payment profile relative to peers in Rheumatology. A higher score indicates fewer or more routine payments.
- Number of Pharma Relationships: 1 pharmaceutical companies
- Drugs/Devices Referenced: 1 distinct products
Payment Breakdown by Category
The following table shows how Dr. Ashley Nelson's pharmaceutical payments break down by payment category. Understanding the mix of payment types provides important context about the nature of the doctor-pharma relationship.
| Payment Category | Amount | Description |
|---|---|---|
| Ownership Interest | $112,809.76 | Ownership stakes, dividends, and investment returns |
The largest payment category for Dr. Ashley Nelson is Ownership Interest, accounting for 100% ($112,809.76) of total pharmaceutical payments received. This indicates a financial ownership interest in a pharmaceutical or medical device company.
Pharmaceutical Company Relationships
The following pharmaceutical and medical device companies have made payments to Dr. Ashley Nelson. Click on any company name to view their full physician payment profile and spending patterns.
| Company | Total Paid | Transactions |
|---|---|---|
| Pfizer Inc | $112,809.76 | 1 |
Dr. Ashley Nelson has a financial relationship with Pfizer Inc, receiving $112,809.76 in total. Having a single pharmaceutical company relationship means all payments come from one source, which may indicate a focused consulting or research relationship.
Drugs and Medical Devices Referenced in Payments
The following drugs and medical devices have been referenced in pharmaceutical payments to Dr. Ashley Nelson. These references indicate that the payment was related to the marketing, consulting, or clinical use of these products.
- Skyrizi -- Referenced in payment records from pharmaceutical companies to Dr. Ashley Nelson
The presence of a drug or device in a payment record means the pharmaceutical company associated the payment with that product. This is common for consulting fees related to a specific medication, speaking engagements about a product, or research involving a particular drug or device.
AI Transparency Analysis
The following analysis was generated by artificial intelligence based on Dr. Ashley Nelson's payment history, specialty peer comparisons, and payment pattern analysis. This analysis is not medical or legal advice.
Ashley Nelson has received $112.8K across 1 pharmaceutical payments as a Rheumatology physician in City, IN. Top paying companies include Pfizer Inc ($112.8K). Dr. Ashley Nelson received a single large payment of $112,810 from Pfizer Inc., which represents the entirety of his pharmaceutical payment profile. The payment was in the form of ownership, indicating a significant financial interest in the company.
Patient Guidance: Questions to Ask Your Doctor
If Dr. Ashley Nelson is your physician, here is practical guidance on how to understand and discuss pharmaceutical industry relationships:
Consumers should be aware of Dr. Nelson's significant financial interest in Pfizer Inc., which may influence his prescribing practices. Always feel free to ask your doctor directly about their pharmaceutical relationships.
Peer Comparison: How Dr. Ashley Nelson Compares to Other Rheumatology Physicians
Compared to peers in Rheumatology, Dr. Nelson's payment is significantly higher, indicating a strong financial relationship with Pfizer Inc.
Recent Payment Records
The following table shows the most recent pharmaceutical industry payments recorded for Dr. Ashley Nelson in the CMS Open Payments database. Click on any payment to view the full report.
| Company | Amount | Type | Drug/Device | Date | Conflict Level |
|---|---|---|---|---|---|
| Pfizer Inc | $112,809.76 | ownership | Skyrizi | 2025-11-02 | Not Assessed |
Frequently Asked Questions About Dr. Ashley Nelson's Pharma Payments
Below are common questions patients ask about physician pharmaceutical payment data.
How much pharma money has Ashley Nelson received?
Ashley Nelson has received a total of $112.8K across 1 payments from pharmaceutical companies. This data is publicly reported under the CMS Open Payments (Sunshine Act) program.
Is Ashley Nelson taking too much pharma money?
Ashley Nelson has received $112.8K in pharmaceutical payments. Whether this is "too much" depends on the physician's specialty (Rheumatology), the types of payments, and how they compare to peers. The largest payment category is ownership ($112.8K). Payment does not imply wrongdoing, but patients should be aware and can ask their doctor directly.
What pharma companies pay Ashley Nelson?
The top pharmaceutical companies paying Ashley Nelson are: Pfizer Inc ($112.8K). These payments cover various categories including consulting, meals, speaking fees, and research grants.
What kinds of payments does Ashley Nelson receive?
Ashley Nelson's payments by type: ownership: $112.8K.
Should I switch doctors because of pharma payments?
Pharma payments alone are not typically reason to switch doctors. Many payments are routine (like meals at educational events) and do not indicate compromised care. Focus on: (1) whether your doctor explains treatment options clearly, (2) whether generic alternatives are discussed, (3) the overall pattern of payments, not individual transactions. If you have concerns, ask your doctor directly.
How do Ashley Nelson's payments compare to other Rheumatology doctors?
To compare, look at the total amount ($112.8K), number of payments (1), and the types of payments received. Rheumatology physicians may receive different payment amounts depending on subspecialty, geographic location, and academic affiliation. Use CMS Open Payments data to compare across the specialty.
How can I verify Ashley Nelson's payment data?
You can verify this data directly through the CMS Open Payments database at openpaymentsdata.cms.gov. Search by physician name or NPI number (1425881981). All data is reported by pharmaceutical companies and verified by CMS. DoctorPharmaData aggregates this public data for easier access.
Do pharma payments affect prescribing quality?
Research published in JAMA Internal Medicine and other peer-reviewed journals shows a statistical association between pharmaceutical payments and prescribing patterns. However, correlation does not equal causation. Many physician-industry interactions are legitimate (research, education, advisory boards). The Sunshine Act was created to promote transparency so patients can make informed decisions.
What stands out about Ashley Nelson's pharma payment profile?
The payment is from a single company, Pfizer Inc., indicating a high concentration of payments from one source. Ashley Nelson has received $112.8K in total pharma payments.
How does Ashley Nelson compare to peers in Rheumatology?
Compared to peers in Rheumatology, Dr. Nelson's payment is significantly higher, indicating a strong financial relationship with Pfizer Inc.
Are Ashley Nelson's pharma relationships typical for Rheumatology?
The payment is in the form of ownership, which is unusual and may raise transparency concerns.
What should patients of Ashley Nelson know about these payments?
Consumers should be aware of Dr. Nelson's significant financial interest in Pfizer Inc., which may influence his prescribing practices.
What patterns are visible in Ashley Nelson's payment history?
The payment amount is substantial, which could be of interest to both peers and consumers.
Understanding This Doctor Payment Report
This transparency report for Dr. Ashley Nelson is based on data from the CMS Open Payments database, which is maintained by the Centers for Medicare and Medicaid Services under the Physician Payments Sunshine Act. Here are important things to understand:
- Payment does not imply wrongdoing. Many pharmaceutical payments represent legitimate professional activities such as consulting on drug development, speaking at medical education events, and conducting clinical research.
- Context matters. A large payment for conducting a clinical trial has very different implications than a large payment for promotional speaking. The payment breakdown by category above provides this context.
- Peer comparison is important. Whether a payment amount is unusual depends heavily on the physician's specialty, geographic location, and career stage. Rheumatology physicians may have very different payment norms than physicians in other fields.
- Data may be incomplete. The CMS Open Payments database captures payments from pharmaceutical and medical device manufacturers. It does not include payments from other sources, such as hospitals, insurance companies, or government agencies.
- Reporting thresholds apply. Small payments below certain thresholds may not be individually reported. The totals reflect payments above reporting minimums set by CMS regulations.
About the Physician Payments Sunshine Act
The Physician Payments Sunshine Act, enacted as Section 6002 of the Affordable Care Act in 2010, requires pharmaceutical and medical device companies to report payments and other transfers of value to physicians and teaching hospitals to CMS. This law was designed to increase transparency in the financial relationships between the healthcare industry and medical providers.
Under this law, Dr. Ashley Nelson's pharmaceutical payments are publicly disclosed. The types of reportable transactions include consulting fees, compensated speaking or educational activities, honoraria, gifts, entertainment, food and beverages, travel and lodging, education or conference attendance, research grants, charitable contributions, royalties or licenses, current or prospective ownership interests, and direct compensation for services other than consulting.
The Open Payments data for Dr. Ashley Nelson and all other physicians can be accessed at the official CMS Open Payments website.
Other Rheumatology Physicians
Compare Dr. Ashley Nelson's pharmaceutical payments with other Rheumatology physicians ranked by total pharma payments received.
| Physician | State | Total Payments |
|---|---|---|
| Elizabeth Roberts | TX | $308,080.83 |
| Susan Taylor | SC | $307,858.47 |
| Paul Turner | WA | $298,822.75 |
| Lisa Garcia | MI | $274,486.60 |
| Jessica Moore | MO | $234,513.43 |
| Jessica Moore | TN | $217,286.77 |
| Andrew Young | CO | $214,519.14 |
| John Anderson | IL | $206,622.12 |
| Patricia Davis | WA | $191,208.57 |
| Catherine Morris | CO | $182,581.01 |
Top Doctors in Indiana
These physicians in Indiana have received the highest pharmaceutical payments. See how Dr. Ashley Nelson compares to peers in the same state.
| Physician | Specialty | Total Payments |
|---|---|---|
| Ashley Nelson | Oncology | $245,077.97 |
| Patricia Davis | Internal Medicine | $229,890.74 |
| Scott Collins | Oncology | $211,272.07 |
| Thomas Miller | Hematology | $203,833.07 |
| Catherine Morris | Oncology | $174,288.79 |
| David Kim | Neurology | $155,605.47 |
| Maria Martinez | Oncology | $141,511.20 |
| Maria Martinez | Hematology | $127,533.80 |
| Richard Brown | Rheumatology | $121,471.94 |
| Charles Baker | Oncology | $98,865.15 |
Related Resources
- Rheumatology Specialty Payment Data -- See payment patterns for all rheumatology physicians
- Indiana Physician Payments -- Browse pharmaceutical payments to physicians in Indiana
- Rheumatology Physicians in Indiana -- Compare Dr. Ashley Nelson to peers in the same state and specialty
- Pfizer Inc Payment Profile -- View all payments made by Dr. Ashley Nelson's largest pharmaceutical partner
- Pfizer Inc Payments to Rheumatology Doctors
- All Medical Specialties -- Browse pharma payments organized by specialty
- All States -- Browse pharma payments organized by state
- Search for Another Doctor or Company -- Look up any physician or pharmaceutical company in our database
- Official CMS Open Payments Database -- Verify payment data directly with the federal government
- NPI Registry -- Look up Dr. Ashley Nelson's NPI (1425881981) in the official provider registry
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.